Related Experiment Video
Updated: Aug 30, 2026
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required
Abstract:
This regulation implements the new threshold requirements and mail order reporting requirements of the Methamphetamine Anti-Proliferation Act of 2000 (MAPA), which was enacted on October 17, 2000. DEA is amending its regulations to reduce the thresholds for pseudoephedrine and phenylpropanolamine for retail distributors and for distributors required to submit mail order reports. Also, DEA is amending its regulations to require mail order reports for certain export transactions. DEA is codifying exemptions from the mail order reporting requirements for certain distributions to nonregulated persons and certain export transactions. This rule is consistent with the intent of MAPA to prevent the diversion of drug products to the clandestine manufacture of methamphetamine and amphetamine, and simultaneously reduce the industry reporting burden.
Insights
New regulations under the Methamphetamine Anti-Proliferation Act (MAPA) reduce thresholds for pseudoephedrine and phenylpropanolamine. These changes aim to prevent illicit drug manufacturing while easing reporting burdens for distributors.
Area of Science:
- Regulatory Affairs
- Pharmaceutical Science
- Criminology
Background:
- The Methamphetamine Anti-Proliferation Act (MAPA) of 2000 established requirements to combat methamphetamine and amphetamine production.
- Previous regulations involved specific threshold and reporting requirements for certain precursor chemicals.
Purpose of the Study:
- To implement revised threshold and mail order reporting requirements mandated by MAPA.
- To reduce the regulatory burden on distributors while enhancing control over precursor chemicals.
Main Methods:
- Amending Drug Enforcement Administration (DEA) regulations concerning pseudoephedrine and phenylpropanolamine.
- Establishing new mail order reporting requirements for specific export transactions.
- Codifying exemptions for certain distributions to non-regulated persons and export transactions.
Main Results:
- Reduced thresholds for pseudoephedrine and phenylpropanolamine for retail and mail order distributors.
- Implementation of mail order reporting for specified export transactions.
- Clarification of exemptions from mail order reporting requirements.
Conclusions:
- The revised regulations align with MAPA's objective to prevent drug diversion for illicit synthesis.
- The amendments aim to streamline reporting processes for the pharmaceutical industry.
- The regulation balances drug control efforts with a reduced industry reporting burden.
